A Qualitative Exploration of Women With Cystic Fibrosis and Urinary Incontinence

Laura Vargas; Traci M Kazmerski; Karen von Berg; Danielle Patterson; Natalie West; Megan Bradley

doi:10.1097/SPV.0000000000001572

A Qualitative Exploration of Women With Cystic Fibrosis and Urinary Incontinence

Urogynecology (Phila). 2024 Sep 19. doi: 10.1097/SPV.0000000000001572. Online ahead of print.

Authors

Laura Vargas¹, Traci M Kazmerski², Karen von Berg³, Danielle Patterson⁴, Natalie West⁵, Megan Bradley⁶

Affiliations

¹ From the University of Pittsburgh School of Medicine.
² Division of Adolescent and Young Adult Medicine, Department of Pediatrics, University of Pittsburgh Medical Center, Center for Innovative Research on Gender Health Equity (CONVERGE), University of Pittsburgh.
³ Department of Physical Medicine and Rehabilitation, Johns Hopkins Hospital.
⁴ Department of Obstetrics and Gynecology and.
⁵ Department of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University.
⁶ Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Urogynecology, University of Pittsburgh School of Medicine.

PMID: 39331807
DOI: 10.1097/SPV.0000000000001572

Abstract

Importance: Women with cystic fibrosis (CF) historically experience a high prevalence of urinary incontinence (UI). However, this area is understudied, especially in the modern era of highly effective modulator therapy (HEMT).

Objective: This study aimed to explore the UI experiences, knowledge, care-seeking behavior, and treatment preferences of women with CF.

Study design: We recruited women aged ≥18 years through the CF Foundation's Community Voice national registry if they had a diagnosis of CF and reported UI. Participants underwent individual, semistructured interviews exploring their experiences, attitudes, and preferences toward UI that were audiorecorded and transcribed. Two coders performed thematic analysis using deductive and inductive coding approaches.

Results: Twenty-six participants completed interviews (average age, 45.1 years; range, 24-61 years). Key themes included the following: (1) most women with CF and UI report low bother from symptoms likely related to stress UI, and HEMT has greatly improved UI symptoms and decreased bother; (2) most women with CF and UI had previously discussed UI symptoms with family and/or peers but had not sought care due to stigma or low priority; (3) women with CF and UI had minimal knowledge about UI in general and how it relates to CF; (4) most desired broad screening for UI from their CF team and improved multidisciplinary care; and (5) highly effective UI treatment options with low-time commitment and easily accessible resources are desired.

Conclusions: Women with CF and UI report low knowledge and care-seeking behavior related to this condition and desire improved care provision. Importantly, HEMT may improve UI symptoms among people with CF.